Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Glucosamine Hydrochloride | Approved | Dona, Xicil, Dolenio, Dona 200-S, Viartril-S | Mainland China | Osteoarthritis | Bright Future Pharmaceutical Laboratories Ltd | 2004-03-17 | Insulin Resistance; Chronic Periodontitis; Osteoarthritis; Obesity | Details | ||
| Charcoal | AST-120; MP-146 | Approved | Kureha Co | Kremezin, Zysa, Kremezin Fine Granules | Japan | Kidney Failure, Chronic | Mitsubishi Tanabe Pharma | 1991-10-04 | Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Pouchitis; Hepatic Encephalopathy; Intestinal Fistula; Asthma; Gastroesophageal Reflux; Renal Insufficiency, Chronic; Kidney Failure, Chronic | Details |
| Mepacrine hydrochloride | CBL-0102; CBLC-102; Curaxin CBLC-102 | Approved | Bayer AG | Atebrin, Maladin, Atabrine, Tenicridine | Lupus Erythematosus, Systemic; Giardiasis; Leishmaniasis; Malaria | Bayer AG | 1932-01-01 | Creutzfeldt-Jakob Syndrome; Carcinoma, Renal Cell; Malaria; Giardiasis; Lupus Erythematosus, Systemic; Prostatic Neoplasms; Leishmaniasis | Details | |
| Anapsos | EQA-00 | Approved | Asac Pharmaceutical International | Psoriacen | Psoriasis; Dermatitis, Atopic | Asac Pharmaceutical International | 1972-01-01 | Psoriasis; Dermatitis, Atopic | Details | |
| Acetylaconitine | Approved | Mainland China | Pain | Shaanxi Xingbang Pharmacevtical Co Ltd | 1985-01-01 | Pain | Details | |||
| Andrographolide/Sodium Hydrogen Sulfite | Approved | Bacterial Infections | Details | |||||||
| Glucosamine Hydrochloride/Chondroitin sulfate | Approved | Details | ||||||||
| Glucosamine Hydrochloride/Indomethacin | Approved | Mainland China | Spondylitis, Ankylosing; Spondylosis; Periarthritis; Arthritis, Rheumatoid; Arthritis | null | 1995-01-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Periarthritis; Arthritis; Spondylosis | Details | |||
| Glucosamine Hydrochloride/Dermatan sulfate | Approved | Details | ||||||||
| Iguratimod | T-614 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | 艾得辛, Colvet, Iremod, Kolbet, Careram | Mainland China | Arthritis, Rheumatoid | Hainan Simcere Pharmaceutical Co Ltd | 2011-08-15 | Graft vs Host Disease; Sjogren's Syndrome; Arthritis, Rheumatoid | Details |
| Anvirzel | Approved | Nerium Biotechnology Inc, Ozelle Pharmaceuticals Inc | Anvirzel | Neoplasms | Details | |||||
| Glucosamine Hydrochloride | Approved | Dona, Xicil, Dolenio, Dona 200-S, Viartril-S | Mainland China | Osteoarthritis | Bright Future Pharmaceutical Laboratories Ltd | 2004-03-17 | Insulin Resistance; Chronic Periodontitis; Osteoarthritis; Obesity | Details | ||
| Charcoal | AST-120; MP-146 | Approved | Kureha Co | Kremezin, Zysa, Kremezin Fine Granules | Japan | Kidney Failure, Chronic | Mitsubishi Tanabe Pharma | 1991-10-04 | Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Pouchitis; Hepatic Encephalopathy; Intestinal Fistula; Asthma; Gastroesophageal Reflux; Renal Insufficiency, Chronic; Kidney Failure, Chronic | Details |
| Mepacrine hydrochloride | CBL-0102; CBLC-102; Curaxin CBLC-102 | Approved | Bayer AG | Atebrin, Maladin, Atabrine, Tenicridine | Lupus Erythematosus, Systemic; Giardiasis; Leishmaniasis; Malaria | Bayer AG | 1932-01-01 | Creutzfeldt-Jakob Syndrome; Carcinoma, Renal Cell; Malaria; Giardiasis; Lupus Erythematosus, Systemic; Prostatic Neoplasms; Leishmaniasis | Details | |
| Anapsos | EQA-00 | Approved | Asac Pharmaceutical International | Psoriacen | Psoriasis; Dermatitis, Atopic | Asac Pharmaceutical International | 1972-01-01 | Psoriasis; Dermatitis, Atopic | Details | |
| Acetylaconitine | Approved | Mainland China | Pain | Shaanxi Xingbang Pharmacevtical Co Ltd | 1985-01-01 | Pain | Details | |||
| Andrographolide/Sodium Hydrogen Sulfite | Approved | Bacterial Infections | Details | |||||||
| Glucosamine Hydrochloride/Chondroitin sulfate | Approved | Details | ||||||||
| Glucosamine Hydrochloride/Indomethacin | Approved | Mainland China | Spondylitis, Ankylosing; Spondylosis; Periarthritis; Arthritis, Rheumatoid; Arthritis | null | 1995-01-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Periarthritis; Arthritis; Spondylosis | Details | |||
| Glucosamine Hydrochloride/Dermatan sulfate | Approved | Details | ||||||||
| Iguratimod | T-614 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | 艾得辛, Colvet, Iremod, Kolbet, Careram | Mainland China | Arthritis, Rheumatoid | Hainan Simcere Pharmaceutical Co Ltd | 2011-08-15 | Graft vs Host Disease; Sjogren's Syndrome; Arthritis, Rheumatoid | Details |
| Anvirzel | Approved | Nerium Biotechnology Inc, Ozelle Pharmaceuticals Inc | Anvirzel | Neoplasms | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Edasalonexent | CAT-1004 | Phase 3 Clinical | Catabasis Pharmaceuticals Inc | Diabetes Mellitus, Type 2; Muscular Dystrophy, Duchenne | Details |
| NF-kappa-B decoy oligonucleotide | MP-40; MP-41; MP-42; AMS-001; SI-3104; AMG-0101; AMG-0102; AMG-0103; S-414114 | Phase 3 Clinical | Anges Mg, Osaka University | Intervertebral Disc Degeneration; Dermatitis, Atopic | Details |
| RGN-259 | Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 | Phase 3 Clinical | National Institutes Of Health | Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica | Details |
| Dazdotuftide | TRS-01 | Phase 3 Clinical | Tarsius Pharma | Glaucoma; Uveitis, Anterior; Uveitis; Ocular inflammation | Details |
| Bardoxolone Methyl | RTA-402; NSC-713200 | Phase 3 Clinical | Kyowa Hakko Kirin Co Ltd, Reata Pharmaceuticals Inc | Cryptogenic Organizing Pneumonia; Melanoma; Kidney Failure, Chronic; Nephritis, Hereditary; Hamman-Rich Syndrome; Lymphoma; Renal Insufficiency, Chronic; Hepatic Insufficiency; Diabetic Nephropathies; Polycystic Kidney, Autosomal Dominant; Glomerulosclerosis, Focal Segmental; Pulmonary Arterial Hypertension; Hypertension, Pulmonary; Lung Diseases, Interstitial; Liver Diseases; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Kidney Diseases; Glomerulonephritis, IGA; Idiopathic Interstitial Pneumonias; Diabetes Mellitus, Type 2; Solid tumours | Details |
| Hypochlorous Acid | PR-013; PR-022 | Phase 3 Clinical | Realm Therapeutics | Cataract; Virus Diseases; Coronavirus Disease 2019 (COVID-19); Endophthalmitis; Conjunctivitis, Allergic; Dermatitis, Atopic | Details |
| Triolex | HE-3286; NE-3107 | Phase 3 Clinical | Harbor Therapeutics, Biovie Inc | Brain Injuries, Traumatic; Diabetes Mellitus, Type 2; Arthritis, Rheumatoid; Insulin Resistance; Alzheimer Disease; Colitis, Ulcerative; Parkinson Disease | Details |
| Fluasterone | ST002; ST001; ST-001; HE-2500; 8354; ST-002 | Phase 2 Clinical | Harbor | Keratosis, Actinic; Cushing Syndrome; Metabolic Syndrome | Details |
| Nanocurcumin (Tehran University of Medical Sciences) | Phase 2 Clinical | Tehran University Of Medical Sciences | Neoplasms; Periapical Diseases | Details | |
| APPA | APPA; AKL-4; AKL-IV; APPA-1 | Phase 2 Clinical | AKL Research & Development Ltd | Osteoarthritis | Details |
| CKBA | CKBA | Phase 2 Clinical | BCY Pharm Co Ltd | Psoriasis; Vitiligo; Plaque psoriasis | Details |
| Manganese butoxyethyl pyridyl porphyrin | BMX-001; MnTnBuOE-2-PyP5+ | Phase 2 Clinical | Duke University | Head and Neck Neoplasms; Rectal Neoplasms; Glioblastoma; Astrocytoma; Carcinoma, Squamous Cell; Glioma; Brain metastases | Details |
| CBL-0137 | CX-137; CBL-0137; CBLC-137; Curaxin-CBL0137 | Phase 2 Clinical | Cleveland Biolabs Inc | Solid tumours; Hematologic Neoplasms; Skin Melanoma; Neoplasms; Glioblastoma; Central Nervous System Neoplasms; Osteosarcoma; Sarcoma; Diffuse Intrinsic Pontine Glioma; Lymphoma; Glioma; Melanoma | Details |
| Ornithine Phenylacetate | OP; L-OP; OCR-002; UCL-L1V; MNK-6105; MNK-6106 | Phase 2 Clinical | University College London | Liver Cirrhosis; Fibrosis; Hepatic Encephalopathy | Details |
| Tepilamide fumarate | PPC-06; XP-23829 | Phase 2 Clinical | Xenoport Inc | Psoriasis | Details |
| YIV-906 | PHY-906; KD-018 | Phase 2 Clinical | Phytoceutica Inc | Liver Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Diarrhea; Hepatitis B; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details |
| GLS-1027 | GIT-27; VGX-1027 | Phase 2 Clinical | Geneone Life Science Inc | Pneumonia; Coronavirus Disease 2019 (COVID-19); Severe Acute Respiratory Syndrome | Details |
| Dimethylaminomicheliolide Fumarate | ACT-001 | Phase 2 Clinical | Tianjin Accendatech Technology Co Ltd | Glioblastoma; Small Cell Lung Carcinoma; Ganglioglioma; Central Nervous System Neoplasms; Optic Neuritis; Neuromyelitis Optica; Breast Neoplasms; Glioma; Brain metastases; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
| Ascorbic Acid/Menadione | Phase 2 Clinical | Ic-Medtech Co, Summa Health System | Joint Diseases; Prostatic Neoplasms | Details | |
| LC-280126 | MIT-001; LC-280126; NecroX-7; LC28-0126 | Phase 2 Clinical | Lg Life Sciences Ltd | Hematologic Neoplasms; ST Elevation Myocardial Infarction; Squamous Cell Carcinoma of Head and Neck; Multiple Myeloma; Lymphoma; Stomatitis | Details |
| Ginsenoside C-K | IH-901; Compound K | Phase 1 Clinical | Rohto, Il-Hwa, Zhejiang Hisun Pharmaceutical Co Ltd, Fudan University, State Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry | Arthritis, Rheumatoid | Details |
| ORYN-1001 | ORTD-1; ORYN-1001 | Phase 1 Clinical | Oryn Therapeutics Llc | Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid | Details |
| CKD-712 | CKD-712 | Phase 1 Clinical | Chong Kun Dang Pharmaceutical Corp | Sepsis | Details |
| LH-025 | LH-025 | Phase 1 Clinical | Dr August Wolff | Colitis, Ulcerative | Details |
| Xempritolimod | KMRC-011 | Phase 1 Clinical | Korea Institute Of Industrial Technology | Acute Radiation Syndrome | Details |
| DEN-181 | DEN-181; CurcusomeRA; CurcusomeTMRA | Phase 1 Clinical | Dendright | Arthritis, Rheumatoid | Details |
| ILB-202 | ILB-202; ILB202 | Phase 1 Clinical | Ilias Biologics Inc | Acute Kidney Injury; Intraoperative Complications | Details |
| SFA-001 | SFA-001; SFA-001N | Phase 1 Clinical | Temple University, Sfa Therapeutics | Metabolic Dysfunction-Associated Steatotic Liver Disease; Fibrosis | Details |
| Proximod | Phase 1 Clinical | Institue Of Materia Medica Chinese Academy Of Medical Science | Arthritis, Rheumatoid | Details | |
| [14C]ACT-001 | [14C]ACT001 | Phase 1 Clinical | Tianjin Xinyi Shangde Biomedical Technology Co Ltd | Solid tumours | Details |
| RHN-002 | RHN-002; RHN002 | Phase 1 Clinical | RH Nanopharmaceuticals LLC | Pain, Postoperative; Anemia, Sickle Cell | Details |
| Hypochlorous Acid/Acetic Acid | SS0350; SS-0350 | Phase 1 Clinical | Softox Solutions As | Leg Ulcer; Varicose Ulcer | Details |
| TLZ-16-CL | TLZ-16-CL | Phase 1 Clinical | Beijing Taizhou Lize Pharmaceutical Technology Co Ltd | Substance Withdrawal Syndrome; Cocaine-Related Disorders | Details |
| OP-101 | OP-101 | Phase 1 Clinical | Ashvattha Therapeutics | Coronavirus Disease 2019 (COVID-19); Adrenoleukodystrophy | Details |
| Anatabine citrate | RCP-006 | Clinical | Rock Creek, Roskamp Institute | Thyroiditis, Autoimmune; Smoking Cessation; Tobacco Use Disorder; Alzheimer Disease; Inflammation | Details |
| Tarenflurbil spraygel (MIKA Pharma) | Clinical | Galen Ltd, Mika Pharma Gmbh | Pain; Arthritis, Rheumatoid; Skin Diseases; Inflammation; Dermatitis, Atopic | Details | |
| RHN-001 | RHN-001; RHN001 | RH Nanopharmaceuticals LLC | Details | ||
| Edasalonexent | CAT-1004 | Phase 3 Clinical | Catabasis Pharmaceuticals Inc | Diabetes Mellitus, Type 2; Muscular Dystrophy, Duchenne | Details |
| NF-kappa-B decoy oligonucleotide | MP-40; MP-41; MP-42; AMS-001; SI-3104; AMG-0101; AMG-0102; AMG-0103; S-414114 | Phase 3 Clinical | Anges Mg, Osaka University | Intervertebral Disc Degeneration; Dermatitis, Atopic | Details |
| RGN-259 | Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 | Phase 3 Clinical | National Institutes Of Health | Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica | Details |
| Dazdotuftide | TRS-01 | Phase 3 Clinical | Tarsius Pharma | Glaucoma; Uveitis, Anterior; Uveitis; Ocular inflammation | Details |
| Bardoxolone Methyl | RTA-402; NSC-713200 | Phase 3 Clinical | Kyowa Hakko Kirin Co Ltd, Reata Pharmaceuticals Inc | Cryptogenic Organizing Pneumonia; Melanoma; Kidney Failure, Chronic; Nephritis, Hereditary; Hamman-Rich Syndrome; Lymphoma; Renal Insufficiency, Chronic; Hepatic Insufficiency; Diabetic Nephropathies; Polycystic Kidney, Autosomal Dominant; Glomerulosclerosis, Focal Segmental; Pulmonary Arterial Hypertension; Hypertension, Pulmonary; Lung Diseases, Interstitial; Liver Diseases; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Kidney Diseases; Glomerulonephritis, IGA; Idiopathic Interstitial Pneumonias; Diabetes Mellitus, Type 2; Solid tumours | Details |
| Hypochlorous Acid | PR-013; PR-022 | Phase 3 Clinical | Realm Therapeutics | Cataract; Virus Diseases; Coronavirus Disease 2019 (COVID-19); Endophthalmitis; Conjunctivitis, Allergic; Dermatitis, Atopic | Details |
| Triolex | HE-3286; NE-3107 | Phase 3 Clinical | Harbor Therapeutics, Biovie Inc | Brain Injuries, Traumatic; Diabetes Mellitus, Type 2; Arthritis, Rheumatoid; Insulin Resistance; Alzheimer Disease; Colitis, Ulcerative; Parkinson Disease | Details |
| Fluasterone | ST002; ST001; ST-001; HE-2500; 8354; ST-002 | Phase 2 Clinical | Harbor | Keratosis, Actinic; Cushing Syndrome; Metabolic Syndrome | Details |
| Nanocurcumin (Tehran University of Medical Sciences) | Phase 2 Clinical | Tehran University Of Medical Sciences | Neoplasms; Periapical Diseases | Details | |
| APPA | APPA; AKL-4; AKL-IV; APPA-1 | Phase 2 Clinical | AKL Research & Development Ltd | Osteoarthritis | Details |
| CKBA | CKBA | Phase 2 Clinical | BCY Pharm Co Ltd | Psoriasis; Vitiligo; Plaque psoriasis | Details |
| Manganese butoxyethyl pyridyl porphyrin | BMX-001; MnTnBuOE-2-PyP5+ | Phase 2 Clinical | Duke University | Head and Neck Neoplasms; Rectal Neoplasms; Glioblastoma; Astrocytoma; Carcinoma, Squamous Cell; Glioma; Brain metastases | Details |
| CBL-0137 | CX-137; CBL-0137; CBLC-137; Curaxin-CBL0137 | Phase 2 Clinical | Cleveland Biolabs Inc | Solid tumours; Hematologic Neoplasms; Skin Melanoma; Neoplasms; Glioblastoma; Central Nervous System Neoplasms; Osteosarcoma; Sarcoma; Diffuse Intrinsic Pontine Glioma; Lymphoma; Glioma; Melanoma | Details |
| Ornithine Phenylacetate | OP; L-OP; OCR-002; UCL-L1V; MNK-6105; MNK-6106 | Phase 2 Clinical | University College London | Liver Cirrhosis; Fibrosis; Hepatic Encephalopathy | Details |
| Tepilamide fumarate | PPC-06; XP-23829 | Phase 2 Clinical | Xenoport Inc | Psoriasis | Details |
| YIV-906 | PHY-906; KD-018 | Phase 2 Clinical | Phytoceutica Inc | Liver Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Diarrhea; Hepatitis B; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details |
| GLS-1027 | GIT-27; VGX-1027 | Phase 2 Clinical | Geneone Life Science Inc | Pneumonia; Coronavirus Disease 2019 (COVID-19); Severe Acute Respiratory Syndrome | Details |
| Dimethylaminomicheliolide Fumarate | ACT-001 | Phase 2 Clinical | Tianjin Accendatech Technology Co Ltd | Glioblastoma; Small Cell Lung Carcinoma; Ganglioglioma; Central Nervous System Neoplasms; Optic Neuritis; Neuromyelitis Optica; Breast Neoplasms; Glioma; Brain metastases; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
| Ascorbic Acid/Menadione | Phase 2 Clinical | Ic-Medtech Co, Summa Health System | Joint Diseases; Prostatic Neoplasms | Details | |
| LC-280126 | MIT-001; LC-280126; NecroX-7; LC28-0126 | Phase 2 Clinical | Lg Life Sciences Ltd | Hematologic Neoplasms; ST Elevation Myocardial Infarction; Squamous Cell Carcinoma of Head and Neck; Multiple Myeloma; Lymphoma; Stomatitis | Details |
| Ginsenoside C-K | IH-901; Compound K | Phase 1 Clinical | Rohto, Il-Hwa, Zhejiang Hisun Pharmaceutical Co Ltd, Fudan University, State Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry | Arthritis, Rheumatoid | Details |
| ORYN-1001 | ORTD-1; ORYN-1001 | Phase 1 Clinical | Oryn Therapeutics Llc | Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid | Details |
| CKD-712 | CKD-712 | Phase 1 Clinical | Chong Kun Dang Pharmaceutical Corp | Sepsis | Details |
| LH-025 | LH-025 | Phase 1 Clinical | Dr August Wolff | Colitis, Ulcerative | Details |
| Xempritolimod | KMRC-011 | Phase 1 Clinical | Korea Institute Of Industrial Technology | Acute Radiation Syndrome | Details |
| DEN-181 | DEN-181; CurcusomeRA; CurcusomeTMRA | Phase 1 Clinical | Dendright | Arthritis, Rheumatoid | Details |
| ILB-202 | ILB-202; ILB202 | Phase 1 Clinical | Ilias Biologics Inc | Acute Kidney Injury; Intraoperative Complications | Details |
| SFA-001 | SFA-001; SFA-001N | Phase 1 Clinical | Temple University, Sfa Therapeutics | Metabolic Dysfunction-Associated Steatotic Liver Disease; Fibrosis | Details |
| Proximod | Phase 1 Clinical | Institue Of Materia Medica Chinese Academy Of Medical Science | Arthritis, Rheumatoid | Details | |
| [14C]ACT-001 | [14C]ACT001 | Phase 1 Clinical | Tianjin Xinyi Shangde Biomedical Technology Co Ltd | Solid tumours | Details |
| RHN-002 | RHN-002; RHN002 | Phase 1 Clinical | RH Nanopharmaceuticals LLC | Pain, Postoperative; Anemia, Sickle Cell | Details |
| Hypochlorous Acid/Acetic Acid | SS0350; SS-0350 | Phase 1 Clinical | Softox Solutions As | Leg Ulcer; Varicose Ulcer | Details |
| TLZ-16-CL | TLZ-16-CL | Phase 1 Clinical | Beijing Taizhou Lize Pharmaceutical Technology Co Ltd | Substance Withdrawal Syndrome; Cocaine-Related Disorders | Details |
| OP-101 | OP-101 | Phase 1 Clinical | Ashvattha Therapeutics | Coronavirus Disease 2019 (COVID-19); Adrenoleukodystrophy | Details |
| Anatabine citrate | RCP-006 | Clinical | Rock Creek, Roskamp Institute | Thyroiditis, Autoimmune; Smoking Cessation; Tobacco Use Disorder; Alzheimer Disease; Inflammation | Details |
| Tarenflurbil spraygel (MIKA Pharma) | Clinical | Galen Ltd, Mika Pharma Gmbh | Pain; Arthritis, Rheumatoid; Skin Diseases; Inflammation; Dermatitis, Atopic | Details | |
| RHN-001 | RHN-001; RHN001 | RH Nanopharmaceuticals LLC | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
